Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Micronucleus quantification from whole-slide haematology images using AI serves as a translatable pharmacodynamic biomarker for DNA damage response inhibitors.

Scientific reports·2026
Same author

Adenine base editor correction of pathogenic variations associated with inherited retinal dystrophy in patient iPSC and retinal organoids.

Molecular therapy. Nucleic acids·2025
Same author

Preventing light-induced toxicity in a new mouse model of sector retinitis pigmentosa caused by Rhodopsin M39R variant.

Cell death discovery·2025
Same author

Raman spectroscopy identified fingernail compositional differences between sexes and age-related changes but not handedness or fingers in a healthy cohort.

PloS one·2025
Same author

RHO-Associated Retinitis Pigmentosa: Genetics, Phenotype, Natural History, Functional Assays, and Animal Model - In Preparation for Clinical Trials.

Investigative ophthalmology & visual science·2025
Same author

Analysis of Interactions Between Pyomelanin and the Extracellular Matrix in an Ex Vivo Turkey Tendon Model.

ChemistryOpen·2025

Related Experiment Video

Updated: Mar 9, 2026

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix
09:00

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix

Published on: February 9, 2015

28.6K

Counteracting bone fragility with human amniotic mesenchymal stem cells.

Anna M Ranzoni1, Michelangelo Corcelli1, Kwan-Leong Hau1

  • 1Institute for Women's Health, University College London, London, UK.

Scientific Reports
|December 21, 2016
PubMed
Summary

Human amniotic mesenchymal stem cells (AFSCs) transplantation improved bone strength and reduced fracture risk in osteogenesis imperfecta mice. AFSCs enhanced bone formation by differentiating into osteoblasts and promoting resident osteoblast maturation.

More Related Videos

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.7K
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

18.0K

Related Experiment Videos

Last Updated: Mar 9, 2026

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix
09:00

Isolation of Human Mesenchymal Stem Cells and their Cultivation on the Porous Bone Matrix

Published on: February 9, 2015

28.6K
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
06:05

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

1.7K
Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots
11:22

Treatment of Osteochondral Defects in the Rabbit's Knee Joint by Implantation of Allogeneic Mesenchymal Stem Cells in Fibrin Clots

Published on: May 21, 2013

18.0K

Area of Science:

  • Stem cell biology
  • Skeletal biology
  • Regenerative medicine

Background:

  • Impaired osteoblast maturation causes bone weakening, leading to conditions like osteogenesis imperfecta (OI).
  • Mesenchymal stem cell transplantation is a potential therapy for skeletal anabolic enhancement.
  • Mechanisms of donor cell contribution to bone health require further investigation.

Purpose of the Study:

  • To investigate the therapeutic potential of human amniotic mesenchymal stem cells (AFSCs) in a mouse model of osteogenesis imperfecta (OI).
  • To elucidate the mechanisms by which AFSCs improve bone health and reduce fracture susceptibility.

Main Methods:

  • Intraperitoneal injection of AFSCs into oim mice (a model for OI).
  • Assessment of bone strength, quality, micro-architecture, and remodeling.
  • Analysis of donor cell engraftment and differentiation.
  • Evaluation of signaling pathways including TNFα and TGFβ.

Main Results:

  • AFSC transplantation reduced fracture susceptibility and increased bone strength in oim mice.
  • Improved bone quality and micro-architecture were observed post-transplantation.
  • Normalised bone remodeling and reduced TNFα and TGFβ signaling were noted.
  • Donor AFSCs engrafted into bone, differentiated into osteoblasts, and promoted endogenous osteogenesis.

Conclusions:

  • AFSC transplantation is a viable countermeasure for bone fragility in OI.
  • AFSCs contribute to bone health through direct differentiation and by promoting resident osteoblast maturation.
  • These findings have significant implications for bone health and fracture reduction strategies.